retatrutide trial news VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide trial news Retatrutide, an

WD repeat-containing protein 5 (WDR5) was later described as a specific reader for H3Q5ser, which deciphers epigenetic signals to activate neurodevelopment-related genetic programs

Similar changes can occur after any rapid or substantial weight loss, including following bariatric surgery or other medically supervised weight-loss programs

But sleep is one of the most powerful metabolic tools available

The terminology is contested, but the underlying observation is not: the metabolic deterioration of neurons, their diminishing capacity to produce and manage energy, appears to be an early and potentially modifiable feature of the disease process, not merely a downstream consequence of it